Skip to main content
YI
NASDAQ Trade & Services

111, Inc. Q2 Loss Widens to RMB39.1M as Cash Drops 38% Amid Asset-Light Pivot

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Negative
Importance info
7
Price
$3.7
Mkt Cap
$29.694M
52W Low
$2.48
52W High
$11.17
52W Position info
49% above low
Off High info
67% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

YI sits 49% above its 52-week low of $2.48.

Summary

111, Inc. reported Q2 2026 results with net loss attributable to ordinary shareholders more than doubling to RMB39.1M and cash dropping 38% to RMB381.1M, while carrying a RMB956.7M redemption obligation. Promotional products revenue grew 121% YoY as the company pivots to an asset-light model.


Key Events · Earnings and Guidance · YI

  • Q2 Net Loss More Than Doubles

    Net loss attributable to ordinary shareholders widened to RMB39.1M (US$5.8M) from RMB19.5M in Q2 2025, driven by a 28.3% revenue decline to RMB2.3B and severance costs from AI-driven workforce streamlining.

  • Cash Position Drops 38%

    Cash, restricted cash, and short-term investments fell to RMB381.1M (US$56.2M) from RMB611.3M at year-end 2025, reflecting continued operating cash burn of RMB103.2M in the first half.

  • RMB956.7M Redemption Obligation

    The company owes RMB956.7M to 1 Pharmacy Technology investors from 2020 equity investments. RMB282.2M has been repaid, and investors holding 63.8% of principal have agreed to extended restructuring terms.

  • Promotional Products Revenue Up 121%

    Net revenue from promotional products reached RMB60.7M (US$8.9M) with 120% gross profit growth, led by Levofloxacin Tablets (Cravit) which grew quarterly sales from 364,000 to 1,041,000 boxes.


Analysis · YI · Trade & Services

The second-quarter results from 111, Inc. reveal a deteriorating financial position that extends well beyond the headline revenue decline. Net loss attributable to ordinary shareholders more than doubled to RMB39.1 million (US$5.8 million) from RMB19.5 million a year earlier, while cash and equivalents fell 38% to RMB381.1 million from RMB611.3 million at year-end. The company is burning cash as it pivots to an asset-light model, and it carries a RMB956.7 million redemption obligation to 1 Pharmacy Technology investors — a liability that has already forced RMB282.2 million in repayments. The silver lining is promotional products revenue, which grew 121% to RMB60.7 million, and an 18.2% increase in marketplace service revenue for the first half. But the balance sheet pressure is real: shareholders' deficit widened to RMB776.3 million, and the company is relying on investor forbearance for 63.8% of the redemption principal. This filing lands the same day as a going-private proposal at US$4.52 per ADS, which may explain why the market is focused on the buyout rather than the deteriorating fundamentals.

How filings like this one have moved

In the 30 days to Oct 3, 2026, 28.9% of the 1666 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, YI was trading at $3.70 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $29.7M. The 52-week trading range was $2.48 to $11.17. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

YI - Latest Insights

YI
Sep 28, 2026, 6:33 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.60
Real-time Price: $3.50 info
Change: -$0.1031 (-3%) info
Market Cap: $28.288M info
YI
Sep 28, 2026, 4:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $3.60
Real-time Price: $3.50 info
Change: -$0.1031 (-3%) info
Market Cap: $28.288M info
YI
Sep 17, 2026, 6:16 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $3.66
Real-time Price: $3.50 info
Change: -$0.1631 (-4%) info
Market Cap: $28.288M info
YI
Sep 17, 2026, 6:08 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $3.70
Real-time Price: $3.50 info
Change: -$0.2031 (-5%) info
Market Cap: $28.288M info
YI
Sep 17, 2026, 4:25 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $3.43
Real-time Price: $3.50 info
Change: +$0.0669 (+2%) info
Market Cap: $28.288M info